[Liebert] Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study

katerina19 Post time 4 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-11-24 01:04
Reward10points

journalㄩThyroid

AuthorsㄩMijin Kim; Meihua Jin; Min Ji Jeon; Eui Young Kim; Dong Yeob Shin; Dong Jun Lim; Bo Hyun Kim; Ho-Cheol Kang; Won Bae Kim; Young Kee Shong; Hee Kyung Kim; Won Gu Kim

Published dateㄩ2023-1-1

DOIㄩ10.1089/thy.2022.0054

PDF linkㄩhttps://www.liebertpub.com/doi/full-xml/10.1089/thy.2022.0054

Article linkㄩhttps://doi.org/10.1089/thy.2022.0054

Article SourceㄩSAGE Publications﹝


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Intermediate member
  • post

  • reply

  • points

    310


Return to the list